Lima Memorial Health System Logo
Approximate ER WAIT TIME
5

Health Library

Fibrinolysis - primary or secondary
     
Print-Friendly
Bookmarks

Fibrinolysis - primary or secondary

Primary fibrinolysis; Secondary fibrinolysis

 

Fibrinolysis is a normal body process. It prevents blood clots that occur naturally from growing and causing problems.

Primary fibrinolysis refers to the normal breakdown of clots.

Secondary fibrinolysis is the breakdown of blood clots due to a medical disorder, medicine, or other cause. This may cause severe bleeding.

Causes

 

Blood clots form on a protein called fibrin. The breakdown of fibrin (fibrinolysis) can be due to:

  • Bacterial infections
  • Cancer
  • Intense exercise
  • Not enough oxygen to tissues

Your health care provider may give you medicines to help blood clots break down more quickly. This may be done if a blood clot causes a heart attack.

 

 

References

Brummel-Ziedins K, Mann KG. Molecular basis of blood coagulation. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 126.

Schafer AI. Hemorrhagic disorders: disseminated intravascular coagulation, liver failure, and vitamin K deficiency. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 166.

Weitz JI. Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 95.

BACK TO TOPText only

 
  • Blood clot formation

    Blood clot formation

    illustration

  • Blood clots

    Blood clots

    illustration

    • Blood clot formation

      Blood clot formation

      illustration

    • Blood clots

      Blood clots

      illustration

    A Closer Look

     

      Talking to your MD

       

        Self Care

         

          Tests for Fibrinolysis - primary or secondary

           
             

            Review Date: 1/25/2022

            Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

            The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
            © 1997- adam.comAll rights reserved.